136 related articles for article (PubMed ID: 11557114)
1. High cyclin E and low p27/Kip1 expressions are potentially poor prognostic factors in lung adenocarcinoma patients.
Hayashi H; Ogawa N; Ishiwa N; Yazawa T; Inayama Y; Ito T; Kitamura H
Lung Cancer; 2001 Oct; 34(1):59-65. PubMed ID: 11557114
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of cell-cycle regulator p27(Kip1) correlates with a shortened survival in non-small cell lung cancer.
Tsukamoto S; Sugio K; Sakada T; Ushijima C; Yamazaki K; Sugimachi K
Lung Cancer; 2001 Oct; 34(1):83-90. PubMed ID: 11557117
[TBL] [Abstract][Full Text] [Related]
3. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
[TBL] [Abstract][Full Text] [Related]
4. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
Lim YJ; Kim YH; Ahn GH; Chun HK; Jang WY; Lee JH; Son HJ; Rhee PL; Kim JJ; Paik SW; Yoo BC; Rhee JC
Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
6. Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.
Nitti D; Belluco C; Mammano E; Marchet A; Ambrosi A; Mencarelli R; Segato P; Lise M
J Surg Oncol; 2002 Dec; 81(4):167-75; discussion 175-6. PubMed ID: 12451619
[TBL] [Abstract][Full Text] [Related]
7. Low expression of p27(Kip1) is associated with tumor size and poor prognosis in patients with renal cell carcinoma.
Migita T; Oda Y; Naito S; Tsuneyoshi M
Cancer; 2002 Feb; 94(4):973-9. PubMed ID: 11920465
[TBL] [Abstract][Full Text] [Related]
8. Cyclin A correlates with carcinogenesis and metastasis, and p27(kip1) correlates with lymphatic invasion, in colorectal neoplasms.
Li JQ; Miki H; Wu F; Saoo K; Nishioka M; Ohmori M; Imaida K
Hum Pathol; 2002 Oct; 33(10):1006-15. PubMed ID: 12395374
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications.
Erlanson M; Portin C; Linderholm B; Lindh J; Roos G; Landberg G
Blood; 1998 Aug; 92(3):770-7. PubMed ID: 9680343
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of the cell-cycle regulatory proteins, Rb, p16MTS1, p21WAF1, p27KIP1, cyclin E, and cyclin D2, in ovarian cancer.
Milde-Langosch K; Hagen M; Bamberger AM; Löning T
Int J Gynecol Pathol; 2003 Apr; 22(2):168-74. PubMed ID: 12649672
[TBL] [Abstract][Full Text] [Related]
12. Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma.
Hayashi H; Ito T; Yazawa T; Ikeda M; Inayama Y; Nakatani Y; Kameda Y; Nakamura N; Kitamura H
J Pathol; 2000 Sep; 192(1):26-31. PubMed ID: 10951396
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma.
Ferreri AJ; Ponzoni M; Pruneri G; Freschi M; Rossi R; Dell'Oro S; Baldini L; Buffa R; Carboni N; Villa E; Viale G
Int J Cancer; 2001 Nov; 94(4):599-604. PubMed ID: 11745451
[TBL] [Abstract][Full Text] [Related]
14. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
15. Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.
Khan AA; Abel PD; Chaudhary KS; Gulzar Z; Stamp GW; Lalani EN
Mol Pathol; 2003 Dec; 56(6):353-61. PubMed ID: 14645699
[TBL] [Abstract][Full Text] [Related]
16. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients.
Al-Moundhri MS; Nirmala V; Al-Hadabi I; Al-Mawaly K; Burney I; Al-Nabhani M; Thomas V; Ganguly SS; Grant C
J Surg Oncol; 2005 Sep; 91(4):243-52. PubMed ID: 16121348
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
19. Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus - correlation with proliferation and clinicopathological parameters.
Watanabe J; Sato H; Kanai T; Kamata Y; Jobo T; Hata H; Fujisawa T; Ohno E; Kameya T; Kuramoto H
Br J Cancer; 2002 Jul; 87(1):81-5. PubMed ID: 12085261
[TBL] [Abstract][Full Text] [Related]
20. Combined examination of p27(Kip1), p21(Waf1/Cip1) and p53 expression allows precise estimation of prognosis in patients with gastric carcinoma.
Liu XP; Kawauchi S; Oga A; Suehiro Y; Tsushimi K; Tsushimi M; Sasaki K
Histopathology; 2001 Dec; 39(6):603-10. PubMed ID: 11903579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
